Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease D. KellarS. N. LockhartSuzanne Craft Original Research Open access 07 April 2021 Pages: 240 - 248
Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer’s Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial H. ChenS. LiuGuowei Huang Original Research 11 May 2021 Pages: 249 - 256
Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data R. E. AmariglioS. A. M. SikkesA4 Study Team Original Research Open access 05 March 2021 Pages: 257 - 262
Environmental Distractions during Unsupervised Remote Digital Cognitive Assessment E. N. MaderoJ. AndersonJ. M. Glenn Brief Reports 17 March 2021 Pages: 263 - 266
Current State of Self-Administered Brief Computerized Cognitive Assessments for Detection of Cognitive Disorders in Older Adults: A Systematic Review E. TsoyS. ZygourisKatherine L. Possin Reviews 24 March 2021 Pages: 267 - 276
Association of Subjective Cognitive Decline with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Longitudinal Studies X.-T. WangZ.-T. WangJin-Tai Yu Reviews 28 May 2021 Pages: 277 - 285
The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD): A Novel Clinical Trials Training Program Tyler BerknessM. C. CarrilloJ. D. Grill Original Research Open access 02 April 2021 Pages: 286 - 291
Mail and Telephone Outreach from Electronic Health Records for Research Participation on Cognitive Health and Aging K. PunCarolyn W. ZhuM. Sano Original Research 24 April 2021 Pages: 292 - 298
Quantifying Recruitment Source and Participant Communication Preferences for Alzheimer’s Disease Prevention Research D. Julbe-DelgadoJ. L. O’BrienJerri D. Edwards Original Research 03 May 2021 Pages: 299 - 305
Platform Trials to Expedite Drug Development in Alzheimer’s Disease: A Report from the EU/US CTAD Task Force P. S. AisenR. J. BatemanEU/US CTAD Task Force CTAD Task Force Paper Open access 24 May 2021 Pages: 306 - 312
The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention X.-X. ZhangY. TianJin-Tai Yu Reviews Open access 10 April 2021 Pages: 313 - 321
Determinants of Post-Operative Cognitive Decline in Elderly People J. CartaillerC. LoyerC. Paquet Brief Reports 07 April 2021 Pages: 322 - 328
Elevated Blood Homocysteine and Risk of Alzheimer’s Dementia: An Updated Systematic Review and Meta-Analysis Based on Prospective Studies M. ZuinCarlo CervellatiG. Zuliani Reviews 07 February 2021 Pages: 329 - 334
Development, Validation and Field Evaluation of the Singapore Longitudinal Ageing Study (SLAS) Risk Index for Prediction of Mild Cognitive Impairment and Dementia Tze Pin NgT. S. LeeS. L. Wee Original Research 26 April 2021 Pages: 335 - 344
Childhood Secondhand Smoke Exposure and Risk of Dementia, Alzheimer’s Disease and Stroke in Adulthood: A Prospective Cohort Study S. ZhouKanran Wang Original Research 24 March 2021 Pages: 345 - 350
Determinants of Medical Direct Costs of Care among Patients of a Memory Center Virginie DauphinotA. Garnier-CrussardP. Krolak-Salmon Original Research 10 April 2021 Pages: 351 - 361
Major Cost Drivers in Assessing the Economic Burden of Alzheimer’s Disease: A Structured, Rapid Review M. Kosaner KließR. MartinsMark P. Connolly Reviews Open access 24 April 2021 Pages: 362 - 370
Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021 A. P. PorsteinssonR. S. IsaacsonI. Rubino Reviews Open access 09 June 2021 Pages: 371 - 386
Can Virtual Scientific Conferences Facilitate Two-Way Learning between Dementia Researchers and Participants? Sarah WalterB. WheatonN. T. Aggarwal Letter to the Editor Open access 25 May 2021 Pages: 387 - 388